Search
for
Sort by
Research 30 of 320
- Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review
- Valproic acid teratogenicity in whole embryo culture is not prevented by zinc supplementation
- Apoptosis May Explain the Pharmacological Mode of Action and Adverse Effects of Isotretinoin, Including Teratogenicity
- Use of chemotherapy during human pregnancy
- British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology
- Isotretinoin treatment of acne and related disorders: An update
- Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010
- Management of acne
- Oral isotretinoin for acne
- Management of Hirsutism
- Adverse Reactions to Oral Retinoids An Update
- Guidelines on the use of finasteride in androgenetic alopecia
- Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism
- Guidelines for the Use of Acitretin in Psoriasis
- 5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Finasteride in Hidradenitis Suppurativa: A “Male” Therapy for a Predominantly “Female” Disease.
- Current concepts in the pathogenesis and treatment of acne
- Risks of Skin, Hair, and Nail Supplements
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Retinoids in Dermatology
- Mechanism of Action of Isotretinoin
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Isotretinoin
- MULTISYSTEM ADVERSE EFFECTS OF ISOTRETINOIN: MECHANISTIC INSIGHTS AND CLINICAL IMPLICATIONS
- Beyond Clinical Efficacy: A Literature Review on the Safety Challenges of Isotretinoin Therapy
- TREATMENT OF ACNE VULGARIS, OR EVERYTHING WE SHOULD KNOW ABOUT ISOTRETINOIN
- NEW PROPRIETARY BRANDS: Gabapentin
- New drugs: Iobenguane sulfate
- New drugs: Agalsidase beta